March 21st 2025
EsoBiotec’s proprietary lentiviral platform primarily enables the immune system to attack cancers but could ultimately offer patients cell therapy treatments delivered in minutes rather than several weeks.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Lilly Plans New US Pharmaceutical Manufacturing Sites in Wake of Trump Tariffs
February 27th 2025Previous domestic capital expansion commitments since 2020 had been made in Research Triangle Park and Concord, both in North Carolina; Kenosha County, Wisconsin; Lebanon, Indiana; and Lilly’s home city of Indianapolis.
Meeting Secondary Packaging Challenges of Innovative Delivery Systems for Biologics
February 5th 2025Rapid market growth in biologics is helping the packaging market expand as well, but the complex nature of biologics and the desire for personalized therapies present unique hurdles to make packaging solutions cost-effective and safe for patients.
Ask the Expert: Product Inspection, Part One; Risk Mitigation in Secondary Packaging
January 23rd 2025Dirk Margosch, Vice President Visual Inspection, Assembly & Secondary Packaging at Vetter Pharma-Fertigung GmbH & Co KG, provides advice on how to respond to defective vials in a batch and how to prevent future problems in secondary packaging.